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2Introduction – Lots of Drug Use; Lots of Harm
Since the 1960s, approaches to drug use have tended to involve criminalisation 
and interfering with supply through policing, customs controls, and education 
(Nutt et al 2007). 
Politicians frequently respond to drug use not by suggesting divergent policies, 
but by persisting with those in existence whilst calling for more intense, 
prohibitive, and punitive measures (Des Jarlais 1995). To be sure, incarceration in 
prisons or drug detention centres of people who use drugs – but have committed 
no other crime – policies which are known to contribute to the increased transmission 
of HIV, hepatitis, and tuberculosis, receive more fervent support than ever (Global 
Commission on Drug Policy 2011; Global Commission on Drug Policy 2012; Kerr 
and Wood 2008). People who use drugs are seen to be “deserving punishment rather 
than deserving health care” (Des Jarlais et al 1995: 1579). 
Globally, criminalisation of and punitive approaches to drug use continue to be 
implemented, in spite of there being little evidence to suggest that these policies 
have yielded positive results, with it being argued that the “global war on drugs 
has failed” (Global Commission on Drug Policy 2011: 4). In spite of its popularity, it 
is stressed that prohibitionism has failed to curb or diminish drug use and associated 
problems, failing even by its own metrics and standards; the astronomical numbers 
of people who use drugs speak for themselves, where estimates1 point to strikingly 
high levels of global drug use. The United Nations Office on Drugs and Crime 
estimate that in 2009, 149-272 million people (3.3-6.1% of the global populace aged 
15-64) “used illicit substances at least once in the previous year” (UNODC 2011: 13). 
Though downward trends in global cocaine and heroin use are noted, these are offset 
by increasing nonmedical/illicit usage of synthetic and prescription drugs (UNODC 
2011). Between 15 and 39 million people are defined as ‘problem drug users’, having 
dependency issues or being people who inject drugs (UNODC 2011).2
1 People who use drugs make up clandestine groups due to criminalisation, stigmatisation, and marginalisation.  
	 This	results	in	difficulties	in	sampling	and	estimating	population	sizes	and	prevalences	(Bluthenthal	et	al	2000;	Degenhardt	and	Hall	2012).
2 Where ‘problem drug user’ is taken to mean “injecting drug use or long-duration/regular use of opioids, cocaine and/or amphetamines”   
	 (EMCDDA	2009),	it	should	be	emphasised	that	the	term	‘problematic/problem	drug	user’	is	by	no	means	universally	accepted	or	uncontested.		
	 This	term,	along	with	‘abuser’	and	‘misuser’	(discussed	below),	is	“often	used	in	an	uncritical,	disparaging	or	hostile	way”,	noted	to	be	misleading		
	 and	universalising	(INPUD	2011).
“prohibitionism has 
failed to curb or 
diminish drug use 
and associated 
problems, failing 
even by its own 
metrics and 
standards”
3Globally, 11-21 million people inject drugs (Degenhardt and Hall 2012). The spread 
of blood-borne infections like hepatitis and HIV has been driven in many states by 
the sharing of injection paraphernalia and equipment, shared due to difficulties in 
obtaining sterile injecting equipment and repressive legislative environments (for 
example see Advisory Council on the Misuse of Drugs 2009; Gibson et al 1999; 
Global Commission on Drug Policy 2012; Degenhardt and Hall 2012; Drucker et al 
1998; Rhodes et al 2002; WHO 2007). The UNODC (2011) estimate that 17.9% of 
people who inject drugs (2.8 million) are infected with HIV. Hepatitis C is even more 
striking in prevalence, considered the “most important infectious disease affecting 
those who inject drugs” (Health Protection Agency et al 2007) with 45.2%-55.3% – 
around 8 million – of people who inject drugs believed to be infected (UNODC 2011),3 
thus accounting for the majority of the infection’s global spread (Rhodes et al 2004). 
Transmission is facilitated in particular through needle sharing, and additionally 
through the sharing of other injection paraphernalia. Resultantly, the probability and 
rate of hepatitis C transmission is substantially higher than that of HIV, which is less 
likely to be spread through sharing of other paraphernalia (Advisory Council on the 
Misuse of Drugs 2009; Nelson et al 2011; Rhodes et al 2004).
There are estimated to be around 104,000-263,000 drug-related deaths every year 
(UNODC 2011). In addition to the risk of blood-borne infections, adverse outcomes 
of drug use include and/or can surround toxicity and overdoses; development of 
dependence; impacts of intoxication (such as traffic accidents, violence, accidental 
injury); adverse impacts upon health from sustained use (such as development of 
mental disorders), and suicide (Degenhardt and Hall 2012; also see Darke and Hall 
2003). Harms can be compounded by the use of more than one drug (Darke and 
Hall 2003; Degenhardt and Hall 2012), and are not confined to the individual: 
substantial financial criminal and policing costs result from ‘wars against drugs’ 
and prohibitive policies, with additional social costs of healthcare and social issues 
(Global Commission on Drug Policy 2011; Nutt et al 2010; UNODC 2011).
I will argue, however, that where harms that may surround illicit drug use are numerous, 
it is laws and policies, along with their justificatory social constructions and stigmas, 
that are responsible for driving and worsening many of these avoidable harms.4 
3	 To	reiterate,	figures	are	estimates	at	best	–	other	estimates	place	this	figure	of	people	who	inject	drugs	with	hepatitis	C	at	10	million	 
	 (Global	Commission	on	Drug	Policy	2013);	a	review	of	available	literature	suggests	between	60%	and	80%	of	people	who	inject	drugs	have	the		
	 infection	(Nelson	et	al	2011).
4	 In	fact,	it	is	these	laws	and	these	social	constructions	that	themselves	hold	what	are	a	myriad	and	diverse	group	of	substances	together	under	the		
	 label	of	what	I	will	refer	to	as	‘drugs’.	The	term	‘drug’	used	to	connote	various	psychoactive,	stimulant,	and	depressant	substances	is	a	relatively		
	 recent	one,	used	in	this	context	predominantly	through	the	20th	century	(see	Seddon	2010).I	will	take	‘drugs’	and	‘drug	use’	to	refer	to	the		 	
	 nonmedically	sanctioned	use	of	drugs,	whether	the	substance(s)	in	question	is/are	illicit,	controlled,	or	prescription.
“There are estimated 
to be around 
104,000-263,000 
drug-related deaths 
every year” 
(UNODC 2011). 
4Where harms may be associated with drug use itself, they are also intersected and 
exacerbated – as well as directly produced – by prohibition, criminalisation, and by 
the so-called ‘war on drugs’, all of which serve to heighten and intensify, rather than 
reduce or ameliorate, the damage associated with drug use. And moreover, the stigma 
and discrimination that justifies and facilitates such laws and policies – legislation 
which is predominantly driven by ideology and moral assumption (as will be discussed) 
– serves only to compound and multiply these harms. In order to illustrate that these 
are broader projects of stigmatisation and social spoiling that have been also used to 
criminalise, marginalise, and demonise groups other than drug users, I will juxtapose 
the social construction and stigmatisation of drug users with that of sex workers 
and LGBTQ people; these groups have all had their agency and self-determination 
similarly undermined, serving to silence and exclude testimony that conflicts with 
disempowering and moralising perceptions and generalisations. In making reference 
to, and in quoting, a wide breadth of reference material, and in straying from an 
analysis focussed entirely on drug-related issues, I hope to consolidate and perhaps 
progress some ideas, and not simply to regurgitate!
Criminalisation and a War on Drugs
(Mis)Understanding Harm
Not only have policies failed in their efforts to diminish drug use or the harms 
surrounding drug use (as I will discuss below), but drug prohibitionism is driven by 
‘fundamental scientific errors’, by bad pharmacology, bad sociology, bad economics 
(Des Jarlais 1995), and by a “politicization and misrepresentation of science” 
(Kerr and Wood 2008: 964).
Understandings of drug-related harm and effect within the context of a criminalising 
paradigm are predominantly moral, not of empirical risk (Nutt et al 2010); legislation 
and media representation and coverage rarely reflect the empirical qualitative or 
quantitative harm caused by drug use (Nutt et al 2007; Nutt 2009; Nutt et al 2011), 
instead confusing attitudes and assumptions regarding the moral (un)acceptability 
of drugs, of people who use drugs, of psychoactive adulteration, and of resultant 
harms to wider society. Processes by which harms are ‘calculated’ and perceived are 
seemingly capricious, as are the processes by which drugs come to be criminalised 
and controlled (Degenhardt and Hall 2012).
Methodologies for composing drug classification systems are rarely transparent, 
serving to reduce confidence in their accuracy (Nutt et al 2007). In the UK, for 
instance, the “current classification system has evolved in an unsystematic way from 
somewhat arbitrary foundations with seemingly little scientific basis” (Nutt et al 
2007: 1047; also see Degenhardt and Hall 2012; Nutt et al 2010: 1558; Taylor et al 2012).
“legislation and 
media representation 
and coverage 
rarely reflect the 
empirical qualitative 
or quantitative harm 
caused by drug use” 
5An alternative multicriteria decision analysis proposed by Nutt et al (2007; 2010; also 
see Taylor et al 2012 for a similar analysis), uses 16 harm criteria that are identified 
and weighted (2010) to address their varying gravities, with 9 harms to the individual 
using drugs, and 7 to wider society. Perhaps unsurprisingly, “findings correlate poorly 
with present UK drug classification, which is not based simply on considerations of 
harm” (Nutt et al 2010: 1558). Heroin, crack cocaine, and methamphetamine are, for 
example, calculated most dangerous to individuals using these substances in the UK. 
Ecstasy and magic mushrooms are amongst the least problematic, in spite of Class 
A rating. Alcohol, heroin, and crack are calculated to do the most damage to others. 
Overall, alcohol was identified as the most harmful substance (Nutt et al 2010), quite 
ironic given its legality.
“Criminalisation 
furthermore creates 
a system whereby 
the drugs people use 
are of dangerously 
unpredictable 
composition”
“Given that the 
global regime of 
drug prohibition 
ensures that there 
is no quality control 
of street heroin, 
the identification 
and removal of 
contaminated heroin 
from circulation is 
impossible, and as 
such, the recurrence 
of such outbreaks 
seems almost 
inevitable”
(INPUD 2013: 3)
The UK A, B, C classification system – and others like it – thus instils little confidence 
as a benchmark of true harm. In the context of empirically calculated harms, it is 
a confusing and misleading measure, serving to reinforce (mis)assumptions and 
generalisations of all ‘drugs’ as harmful, and of higher classifications as more harmful 
than lower. Criminalisation furthermore creates a system whereby the drugs people 
use are of dangerously unpredictable composition. Where ecstasy/MDMA, for 
instance, is ranked in the Nutt publications as considerably safer to the individual 
than many other substances (including alcohol), the dangers of production on an 
unregulated, illegal black market has resulted in several individuals dying this year 
due to apparent impurities of PMA (para-Methoxyamphetamine) (Pidd 2013); this is 
a highly dangerous compound, resulting in high morbidity and mortality (Caldicott et 
al 2003), far more detrimental than MDMA, ideally the active ingredient in ecstasy. 
Additionally, several people have contracted anthrax from contaminated heroin over 
the last year (Press Association 2012). Ecstasy and heroin are both ‘Class A’ drugs 
in the UK, perplexing given the two substances’ very divergent effects, the nature of 
potential harms, and the overall severity of harm (see Nutt et al 2010); in practice, 
the above harms and deaths associated with use of these two drugs stem from their 
criminalisation and black market production and provision, rather than from the 
drugs themselves, as illustrated by the International Network of People who Use 
Drugs in relation to the aforementioned anthrax deaths: 
Given that the global regime of drug prohibition ensures that there is no quality 
control of street heroin, the identification and removal of contaminated heroin 
from circulation is impossible, and as such, the recurrence of such outbreaks seems 
almost inevitable” (INPUD 2013: 3)
6That these drugs resulted in harm and deaths is not indicative of the harms of drug use, 
but instead of the unsafe and illicit production of drugs and the fact that individuals 
are unable to guarantee or establish the quality or nature of the drugs they buy, and 
(by and large) the drugs they sell, due to criminalisation. Criminalisation therefore, 
in serving to create and/or exacerbate harm, ironically, circularly, and perversely 
justifies itself – harmful criminalisation – a vicious cycle that further amplifies harm 
to both the consumers of the drugs themselves, and to wider society. 
Criminalisation: Precipitating Harm, 
Opposing Harm Reduction
“critics would argue that prohibition itself is responsible for a substantial 
proportion of drug-related harm”. 
(Stevens 2012: 9). 
“A distinctive characteristic of drug policy is the prominence and variety of 
unintended consequences, primarily negative”. 
(Reuter and Trautmann 2007: 46)
“an approach to drug use that is primarily the responsibility of law enforcement 
officials rather than health care personnel results in corruption, abuses, and 
reluctance on the part of drug users to access even the most basic disease 
prevention services”.
(Open Society Institute 2009: 7)
“This report details a wide range of human rights violations committed in the 
name of drug control… These abuses, reported from all regions worldwide,  
are abhorrent and must be combated”. 
(Jürgens et al 2010)
In addition to making drugs themselves more dangerous, the ‘war on drugs’ has, in 
practice, resulted in a war on people who use drugs (Buchanan and Young 2000; 
Open Society Institute 2009), in turn fuelling drug production- and trafficking-
related violence globally (Global Commission on Drug Policy 2012; Reuter and 
Trautmann 2007). The very criminalisation and stigmatisation that prohibition 
relies upon to control and suppress drug use has been of enormous detriment to the 
welfare and health of people who use drugs, as well as the communities in which 
they live (Degenhardt and Hall 2012; Des Jarlais 1995; Global Commission on Drug 
Policy 2012).  
7Drug users face violence, executions, incarcerations, abuse, and discrimination from 
the police and state, and can experience discrimination, stigmatisation, and exclusion 
from service and healthcare provision (including exclusion from antiretroviral therapy 
for HIV), as well as in civil society generally (Jürgens et al 2010; Open Society Institute 
2009). Evidence-based and cost-effective assistance, treatment, and/or intervention are 
frequently sidelined in favour of punishment and incarceration (Drucker et al 1998; 
Global Commission on Drug Policy 2011) which fails, as discussed, to demonstrably 
diminish drug use or drug-related harm.
Alongside the varying and confused illegality of drugs, the harm done by 
criminalisation, and the failure of the war on drugs to decrease drug consumption, 
criminalising discourse and the policies that result both serve to hinder harm 
reduction measures, efforts designed to reduce the harms (notably the transmission 
of blood-borne infections such as HIV) that may be associated with drug use (Global 
Commission on Drug Policy 2011; Global Commission on Drug Policy 2012), and 
that I will discuss in more detail below. Opposition to harm reduction has been 
directed towards other groups too, with examples including opposition to condoms 
and dental dams in prisons (Yap et al 2007), tied in with an intolerance of same-sex 
sexual practice (Dolan et al 1995), and problematisation of harm reduction initiatives 
for commercial sex workers (for arguments in opposition to sex work-related harm 
reduction, see Farley 2004; Raymond 2004; for analysis of opposition to sex work-
related harm reduction, see Brooks-Gordon 2006; Levy 2011b; Weitzer 2008), all 
for fear that these initiatives would encourage and/or facilitate unwanted activities 
(problematised sex, sex selling, drug use, and so forth).
As a result of prohibitionist narrative and concerns surrounding harm reduction, 
healthcare initiatives for drug users may be aborted (Tammi 2005). Most people who 
inject drugs, for example, do not have access to harm reduction programmes, service 
provision, or medical treatment; as the Global Commission on Drug Policy recently 
reported (2012: 2; also see Mathers et al 2010), “a number of specific countries, 
including the US, Russia and Thailand, ignore scientific evidence and World Health 
Organization recommendations and resist the implementation of evidence-based HIV 
prevention programs – with devastating consequences”. Indeed, as of 2012 the US 
has reinstated a federal ban on funding needle and syringe programmes, just three 
years after it was overturned in 2009 (US Office of National Drug Control Policy 
2012), jeopardising harm reduction initiatives funded by the US in several nations 
(Albers 2012). 
“Evidence-based 
and cost-effective 
assistance, treatment, 
and/or intervention 
are frequently 
sidelined in favour 
of punishment and 
incarceration 
(Drucker et al 1998; 
Global Commission on 
Drug Policy 2011) 
which fails, 
as discussed, 
to demonstrably 
diminish drug use or 
drug-related harm.”
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Modes of facilitating safer drug use are frequently opposed where they appear to 
undermine prohibitionist messages (Des Jarlais 1995), and are seen to facilitate 
and endorse drug use (Hedrich et al 2010; Hurley et al 1997; Rhodes 2006). Harm 
reduction initiatives may therefore not be assessed on their merits, but instead in the 
context of consistency with cultural and social traditions (Des Jarlais 1995), with the 
established rhetoric of prohibition. A politicisation of research can further ideological 
ends, to the detriment of pragmatic, health-orientated policies.
“methods used to discredit some research have become more diverse and have 
included funding seemingly independent scientific organizations, quasi-journalist 
outlets and public relations firms, and lobbying for political appointments to 
promote special interests”.
(Kerr and Wood 2008: 964)
“The war on drugs has also led to a policy distortion whereby evidence-based 
addiction treatment and public health measures have been downplayed or ignored.”
(Global Commission on Drug Policy 2012: 2)
There are concerns, for example, that needle and syringe programmes “might 
exacerbate illicit drug use” (WHO 2004: 8; also see Stimson 1989), may increase 
injection frequency, needle sharing with other people who inject drugs, numbers of 
publicly discarded needles, and may serve as a disincentive for people who use drugs 
to cease their drug use, all of which have resulted in opposition to needle and syringe 
programmes (WHO 2004).5 There has, however, been no convincing empirical 
evidence justifying these concerns (see WHO 2004 for a review of available evidence), 
or justifying similar concerns raised regarding safe drug consumption rooms
(Hedrich et al 2010). 
Further to concerns that harm reduction may encourage or endorse drug use, there 
is a fear that these policies will be a ‘slippery slope’ towards liberalisation of drug 
control laws, and will ultimately result in drug legalisation; a blanket condemnation 
of ‘drugs’ has resulted in opiate substitution programmes – such as methadone or 
buprenorphine substitution for heroin – being seen to be problematic (Drucker et al 
1998), perceived as “simply substituting one drug for another” (Des Jarlais 1995: 1580),
5	 Other	initiatives	–	some	of	which	actively	encourage	risky	activities	such	as	needle	sharing	–	can	be	advocated	in	preference	to	needle	and	syringe 
		 programmes:	it	has	been	suggested	that	where	needles	are	being	shared,	those	who	are	HIV	positive	should	inject	last	as	a	harm	reduction	 
	 initiative	(Amundsen	et	al	2003).	This	fails	to	engage	with	the	time	taken	to	seroconvert,	whilst	assuming	all	people	who	inject	drugs	are	 
	 constantly	aware	of	their	serostatus.	Testing	and	counselling	are	also	put	forward	as	preferential	alternatives,	as	they	are	not	seen	to	facilitate	or	 
	 encourage	drug	use	as	needle	and	syringe	programmes	are	(seeAmundsen	et	al	2003;	Käll	et	al	2007),	and	it	is	argued	that	the	implementation	of	 
	 these	programmes	will	result	in	a	peripheralisation	of	such	preferable	initiatives.	This	is	in	spite	of	the	fact	that	it	is	argued	that	needle	and	 
	 syringe	programmes	should	operate	within	a	larger	infrastructure	and	context	of	service	provision	(Advisory	Council	on	the	Misuse	of	Drugs	2009; 
		 Darke	and	Hall	2003),	not	in	isolation	or	as	replacement	initiatives	for	existent	measures.
“A politicisation of 
research can further 
ideological ends, 
to the detriment of 
pragmatic, health-
orientated policies”
9and thus essentially seen to endorse drug use, irrespective of positive results of 
these programmes. Along these lines, in the UK Home Office’s recent outline of 
drugs strategy there is specific opposition to substitution treatment, constructed as 
“replacement of one dependency with another” (Home Office 2012: 10). This is an 
apparent opposition to dependency per se, irrespective of the report conceding that 
some on opiate substitution “have jobs, positive family lives and are no longer taking 
illegal drugs or committing crime”. The title of the report – ‘Putting Recovery First’ 
– is clear, as is the above quotation regarding opiate substitution treatment: however 
unproblematic, successful, and stable the life of a drug user may be, the point is that 
their drug use renders them inferior to a drug/dependence-free equivalent. This leads 
us on to the harm of stigma.
The Harms of Social Spoiling,  
Social Construction, and Language
The stigmatisation and criminalisation of drug users work together, with the former 
used to discourage drug use (Ahern et al 2007; Room 2005), and the latter justified 
by the social spoiling accomplished by the former (Ahern et al 2007). Stigma, in 
addition to criminalisation, serves to drive people who use drugs underground, acting 
as a disincentive to seek healthcare and service provision, and further isolating and 
alienating people who use drugs from normative society and reducing opportunities 
for education and outreach, thus again exacerbating harm to both people who use 
drugs and wider society (Ahern et al 2007; Degenhardt and Hall 2012; Drucker 
et al 1998; Global Commission on Drug Policy 2012). Stigma can serve to justify 
police abuses and general discrimination (Jürgens et al 2010), and vulnerability to 
HIV and sexually transmitted/blood-borne infection is accentuated by stigma and 
discrimination, as well as violence and sexual violence (Logie et al 2011; WHO 
2005b). Stigma can be compounded and intersected, with drug use becoming a 
double, triple, or quadruple stigma in the context of (perceived or assumed) sex work, 
HIV status, and LGBTQ status (Faden et al 1991; Kayal 1993; UNAIDS 2009). In 
short, “overlapping, multilevel forms of stigma and discrimination are representative 
of an intersectional model of stigma and discrimination” (Logie et al 2011). In 
understanding why stigma can do so much harm, it is essential to understand and 
unpack how stigma and the assumptions made of people who use drugs (as well as of 
other stigmatised groups) come to be constructed and – for the most part – accepted 
without question.
“Psychoactive substance use occurs in a highly charged field of moral forces”.
(Room 2005: 152)
“Stigma can be 
compounded and 
intersected, with 
drug use becoming 
a double, triple, or 
quadruple stigma 
in the context 
of (perceived or 
assumed) sex work, 
HIV status, and 
LGBTQ status” 
(Faden et al 1991; 
Kayal 1993; 
UNAIDS 2009).
10
‘Stigmatisation’ refers to a process of social spoiling, where one’s identity or social 
status is tainted or corrupted, as seminally discussed in Goffman’s (1967) Stigma 
– Notes on the Management of Spoiled Identity. Criminality is not the only factor 
driving stigmatisation: what is key is the fact that where an individual uses a deviant 
substance, they are socially tarnished, irrespective of law (though law certainly does 
its part to both drive and, circularly, be driven by this tarnishing process). This 
perspective, that to use ‘drugs’ is to be, by default, a problematic individual, tells us 
that those who use drugs are certain ‘types’ of people, are not as socially valuable or 
complete as those who do not use drugs, as discussed above in relation to perceptions 
of opiate substitution treatment. Ongoing criminalisation, (mis)representation, 
and conflation of drugs, with little attention to their variable harms or intricacies 
of consumption, coupled with a medicalisation of addiction as disease (which will 
be discussed in detail) (Keane 2002) and “taken-for-granted connotations of the 
term ‘addiction’” (Larkin et al  2006: 207, my emphasis) – as well as other loaded 
terminology, as also discussed below – have fed through into the construction and 
stigmatisation of people who use drugs themselves, not just of the drugs that they use. 
Metaphor and social construction – expressed through the vessels of language and 
terminology – feed into and are fed by stigma in turn. Indeed, language is what feeds 
the abovementioned ‘taken-for granted connotations’ of drugs and drug users. Simple 
language is often mistaken for a true, neutral, and accurate representation of Reality 
(Derrida in Wilchins 2004). Where we give metaphorical and/or analogous meaning 
in order to understand, however, the resultant meaning can be a powerful, political, 
and moralistic (or, at least, not an objective) one, where people may be defined 
using metaphor, assumption, social construction, and presupposition (Sontag 1989), 
people made to conform to language instead of language merely describing people 
(Wilchins 2004):
“Derrida pointed out that Western thought has always overvalued or privileged 
language – so much so that we mistake language for the Real… Difference and 
exclusion are not incidental to language but are integral to how we create meaning”.
(Wilchins 2004: 38; 40)
To downplay the power and implications of language, of pejorative words like ‘addict’ 
and ‘junkie’, as well as loaded metaphors like ‘war’, ‘fight’, ‘enemy’, is to deny very 
real and very palpable signification that operates hand-in-hand with criminalisation 
in controlling and subjugating people who use drugs.
11
Even terms such as ‘drug users’ can be argued to be problematic, rendering as noun 
(and thus as identity) what can simply be described with adjectives used to describe 
people (‘people who use drugs’), with terms such as ‘user’ also having somewhat 
parasitic connotation, and ‘drug abuse(r)’ suggesting violence, manipulation, and 
mishandling. Prohibitionist terms – the ‘war on drugs’, for example – have now been 
long tried and tested, used to create reaction and response – much like the use of a 
‘war on AIDS’ in the 1980s (see Sherry 1993). As the war metaphor became more 
significant and widely deployed in the context of the HIV/AIDS pandemic, different 
roles and meanings became significant: the target was to fight and wage war on 
AIDS, with the vectorised ‘victims’ of the disease distanced from but paradoxically 
turned into the actual enemy (Ross 1989). The enemy of a ‘war on drugs’ is similarly 
clear: the users of drugs rather than the drugs themselves. Other taken-for-granted 
terms, which may appear superficially benign, deserve our attention. To be ‘clean’, for 
instance, as well as connoting ‘drug-free’ (or, in the case of blood-borne and sexually 
transmitted infections like HIV, ‘infection-free’) also implies that to occupy the 
opposite position in this binary – in this case, to be a drug user – is to be conversely 
‘dirty’, and thus to be “of less worth and, as such, [these terms] can denigrate and 
marginalise” (INPUD 2011); similarly, as Keane has aptly noted in her intricate 
analysis of the social construction of addiction, even the seemingly inert
“words ‘chemical’ and ‘substance’ cannot be used to avoid the morally and politically 
loaded cultural category of drugs. The term ‘chemical’ has its own powerful negative 
connotations, particularly when juxtaposed with a notion of the body as organic 
and natural”. (Keane: 2002: 18)
Addiction as Disease: Precipitating Stigma, 
Undermining Agency
Following on from a construction and labelling of ‘addiction’ – a term and concept which 
deserves specific focus – is an attendant pathologisation, with dependence coming to 
be understood, constructed, and indeed assumed to be a disease displaying symptoms 
(see Jellinek 1960; also see Keane 2002; Larkin et al 2006; Vrecko 2010). Though I 
do not wish to spend considerable time debating the merits of an understanding of 
addiction-as-disease here, it should be emphasised that this perception is not without 
its problems and contentions. It is facile to unquestioningly accept this construction of 
addiction-as-disease when, like apparent conditions socially constructed to be mental 
disorders (note ‘disorder’, implying a divergence from an ordered state, as opposed 
to ‘disease’, arguably implying pathogen, infection, and/or distinct and consistent 
symptoms with a specific cause, for example), addiction can be argued to be a disease 
for little more than it deviating from a condition seen to be normative (Room 2005),
“To be ‘clean’, for 
instance, as well 
as connoting ‘drug-
free’ (or, in the case 
of blood-borne and 
sexually transmitted 
infections like HIV, 
‘infection-free’) 
also implies that to 
occupy the opposite 
position in this binary 
– in this case, to be a 
drug user – is to be 
conversely ‘dirty’, 
and thus to be 
“of less worth and, as 
such, [these terms] 
can denigrate and 
marginalise” 
(INPUD 2011)
12
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a condition which is variable and reconstructed in differing contexts and time;6 
addiction thus seems incongruous with an empirically and consistently demonstrable 
‘disease’. Apparent symptoms and signifiers of addition being disease are therefore 
uncertain, contextual, and mutable (Keane 2002):
“Addiction-as-disease is not as discrete or as readily identifiable an entity as many 
people believe it is. One of the principal reasons for this is that the user behaviors 
presumed to constitute it are protean, forged in interaction with features of users’ 
environments. What are taken as empirical indicators of an underlying disease of 
addiction consist of a broad range of behaviors that are interpreted as ‘‘symptoms’’ 
only under some circumstances. They can be aggregated to fit under the heading of 
‘‘addiction’’ only by means of some degree of epistemic force”.
(Reinarman 2005: 307)
“The more effort is put into finding answers, the more questions keep proliferating. 
What kind of thing is addiction? Is it a disease or a syndrome or a psychological 
process? Is it a metaphorical disease or a real one (and what exactly is the difference)? 
If it is a disease what are its symptoms? How do its physical, psychological and 
social factors interact and what is their relative importance?”
(Keane 2002: 10)
In short, the meaning and (questionable) ontology of ‘addiction’ is not clear, 
consistent, or stable. The World Health Organisation recommended as early as the 
1960s that the terms ‘addiction’ and ‘addict’ be abandoned in favour of ‘dependence’, 
arguably a more nuanced, less reductive descriptor as opposed to the muddy identity/
disease label of ‘addict/addiction’, yet, the terms addict/addiction are still commonly 
used by healthcare professionals and in mainstream parlance (WHO n.d.). Indeed, 
though I refer to David Nutt’s work elsewhere in this paper as a positive critique 
and deconstruction of drug policy and popular understanding, his recent book takes 
it as given that addiction is a disease, also using the terms ‘addict’ and ‘addiction’ 
unquestioningly (Nutt 2012); a lost opportunity, perhaps, to fully criticise the 
assumptions commonly made about drugs and those who use them.
Though stigma that can surround psychoactive drugs is variable, with the 
moderate and contextual use of drugs such as alcohol not necessarily seen in a 
negative light, the stigma surrounding ‘addiction’ and ‘addicts’ is ‘generalised and 
ubiquitous’ (Room 2005), justified and concretised by aforementioned medically-
sanctioned pathologisation.  
6	 This	is	illustrated	well	by	the	temporal	variation	in	what	is	considered	to	be	disease	or	disorder,	mirroring	what	and	when	various	states	are		
	 contrived	as	deviant,	or	rendered	as	normative.	The	pathologisation	of	gay	and	transgender	people	provides	good	example,	and	is	discussed		
 further below.
“The World Health 
Organisation 
recommended 
as early as the 
1960s that the 
terms ‘addiction’ 
and ‘addict’ be 
abandoned in favour 
of ‘dependence’”
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People who use drugs and people seen to be ‘addicts’ are assumed to be lying, 
manipulative, problematic (Ning 2005), and dirty (Room 2005) – we can see how 
these assumptions tie in with loaded terms such as ‘clean’, discussed above. Simply 
the term ‘addict’ is so imbued with these connotations that they need little by way of 
specific mention. The double-edged stigma of pathology/criminality, of disease/(im)
morality (Larkin et al 2006) that surrounds people who use drugs in many societies 
informs “the traditional view in which the user is perceived as either a criminal or a 
sick person” (Tammi and Hurme 2006: 2). 
In addition to being constructed as pathological and dangerous criminals, those with 
drug dependencies are paradoxically seen through the addiction-as-disease model 
as being rendered helpless by ‘addiction’, serving to undermine agency and self-
determination: individuals are “infantilised and pathologised by the presumption of 
powerlessness” (Keane 2002: 191). The idea that ‘denial’ signifies addiction further 
undermines the autonomy, and in turn the professed views, of people who use drugs 
(Keane 2002). This has come to justify coercive and compulsory care (Keane 2002; 
also see Wild 2005),7 treatment that is “not ethical for any group, as it breaches the 
standard of informed consent” (Stevens 2012: 7); such is the power of terminology, 
of metaphor, of assumption and social construction. In addition, this discourse has 
facilitated a marginalisation and silencing of the voices of people who use drugs 
themselves, especially those who do not wish to conformingly identify as passive, 
pathological ‘victims’ (Keane 2002), thus serving to exclude narratives that threaten 
to destabilise and muddy crude assumptions and understandings of drug users as 
mentally unstable and inept people lacking agency and/or as dangerous criminals.
There are similarities between this disempowering pathologisation of people who 
use drugs – with their agency and self-determination undermined by a narrative of 
‘addiction’ and ‘intoxication’ – and a ‘false consciousness’ model that undermines 
the agency of sex workers. False consciousness is understood to be a phenomenon 
undermining the agency of the individual (originally in the context of Engels’ analysis 
of the working classes’ oppression by the bourgeoisie) whereby the individual 
“imagines false or apparent/seeming motives” (Engels 1893), thus only appearing to 
be conscious and self-aware in their decision making and assumed exploitation. 
7	 Jürgens	et	al	(2010)	note	coercive	care	in	Burma,	Cambodia,	China,	Indonesia,	Laos,	Malaysia,	Thailand,	and	Vietnam.	Compulsory	treatment	for	 
	 dependency	also	takes	place	in	Europe,	with	Sweden’s	‘Care	of	Misusers’	law	allowing	for	such	involuntary	treatment.
“The double-edged 
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(Larkin et al 2006) 
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(Tammi and Hurme 2006: 2)
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As with abovementioned pathologisation, sex workers are pathologised in some 
radical feminist discourse,8 with mental disorder seen to result from sex work itself 
and also from childhood abuse, asserted to act as a precursor to selling sex (Farley 
2004; Farley 2006; Jeffreys 1997; O’Connor and Healy 2006; Raymond 1998). 
These arguments thus undermine sex workers’ agency in selling sex; sex workers’ 
testimony that diverges from a radical feminist model of abuse and desperation in 
sex work is explained away, the sex worker in question being deemed to be either 
unable to engage with the abuse in their sex work, or simply seen to be denying it as 
a coping strategy (for example, see Jeffreys 1997; Raymond 2003). Thus, by using 
a model of false consciousness, radical feminist discourse undermines sex workers’ 
narratives and experiences that diverge from a model of trauma, abuse, and violence: 
“(t)he problem… is in deciding which prostituted and ex-prostituted women to listen 
to” (Jeffreys 1997: 77). Commonalities in social construction of sex workers and 
drug users do not end there, where historically, sex workers have been pathologised 
and problematised as deviant, immoral, sociopathic, psychopathic, and hypersexual 
(Baldwin 2005; Hubbard 1999), “vicariously associated with crime, disease, pollution 
and poverty” (Hubbard 1999: 100).
As with a disempowering ‘addiction’ discourse, models of (or, at least, markedly 
similar to) false consciousness and pathologisation are used to explain away the 
agency of subordinate and/or problematised groups. Parallels with other groups 
seen to be deviant and socially other are striking. A similar medicalisation of 
homosexuality and pathologisation of LGBTQ people has historically been used to 
disempower and justify discrimination towards these groups, and is still used by some 
to strip LGBTQ people of their agency and to justify infantilisation, stigmatisation, 
discrimination, ‘intervention’ and ‘treatment’ in the form of – sometimes medically 
sanctioned and practiced, and sometimes under pressure or coercion, as with some 
treatments for addiction – ‘gay cures’ (Daniel 2009), and coerced sex reassignment 
surgery (Kaplan 2004). This pathologisation is, perhaps, most conspicuous today in 
the case of transgender people, with a construction of ‘gender identity disorder’ used 
to pathologise trans people as, by default, mentally ill (Lev 2005). As recently as 
the early 1970s, gay people too were pathologised in the DSM9 (Lev 2005), and the 
pathologisation and stigmatisation of people who use drugs remains, for the most 
part, unquestioned and assumed today.
“A similar 
medicalisation of 
homosexuality and 
pathologisation 
of LGBTQ people 
has historically 
been used to 
disempower and 
justify discrimination 
towards these 
groups,”
8	 This	radical	feminist	understanding	of	sex	work,	with	sex	work	seen	to	an	ultimate	expression	of	patriarchal	subjugation	of	women,	has	directly	 
	 informed	Sweden’s	1999	criminalisation	of	the	purchase	of	sex.	As	with	criminalising	drugs	legislation,	the	law	has	resulted	in	increased	stigma,	 
	 social	exclusion,	difficulties	with	service	providers,	and	harm	(Levy	2011).	
9	 DSM:	Diagnostic	and	Statistical	Manual	of	Mental	Disorders,	published	by	the	American	Psychiatric	Association.	Recent	criticism	of	the	DSM	 
	 adding	and	removing	apparent	psychological	disorders	(Dailey	2013)	goes	some	way	to	demonstrate	the	mutability	and	inconsistency	of	what	we	 
 understand to be disease and disorder.
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The Empirical Harm of Drugs
As I hope to have demonstrated, the harms associated with drug use are increased 
through unrealistic and unempirical attempts to abolish drug use through repression, 
criminalisation, and stigmatisation. Prohibition is primarily driven morally and 
ideologically, not by evidence of effectiveness for the reduction of harm or, in fact, 
the reduction of drug use.
Since prohibitionist policies have failed to decrease drug-related harms, it seems 
that comprehensive legal reform is needed, with an end to the criminalisation and 
stigmatisation of people who use drugs ‘urgently’ called for (Global Commission 
on Drug Policy 2011). Indeed, “decriminalisation or depenalisation of drugs for 
personal use have been widely recommended” (Jürgens et al 2010). A challenging 
alternative discourse “based on a formal assessment of harm rather than on prejudice 
and assumptions” (Nutt et al 2007: 1052; also see Tammi 2005) is advocated as 
an alternative to crude and morality-driven criminalisation and (mis)classification. 
Pragmatism and nuance in terms of harm are emphasised, where “one must move 
from an ‘all drug use is bad’ stance to a ‘some drug use is much worse than other drug 
use’ perspective” (Des Jarlais et al 1995: 1579). Nutt et al’s (2007; 2010) multicriteria 
analyses, for example, that address multiple harms – both to the individual, and to 
society – is surely more empirically grounded and realistic than policy and analysis 
with a foundation of assumption, ideology, morality, and stigma. 
Harm Reduction
With prohibition-driven harms arguably increasing globally, the need for a public 
health and harm reduction perspective in order to avoid further cost and harm is 
emphasised (International Federation of Red Cross and Red Crescent Societies 2003; 
WHO 2005). Law enforcement and harm reduction are not necessarily mutually 
exclusive (Stevens et al 2010), and it is argued that “(l)aw enforcement efforts should 
focus not on reducing drug markets per se but rather on reducing their harms” 
(Global Commission on Drug Policy 2011). 
Reducing the likelihood of transmission of blood-borne infections and providing 
healthcare to people who use drugs, in particular for those who inject,  may be 
achieved by (for example see Advisory Council on the Misuse of Drugs 2009; Drucker 
et al 1998; Gibson et al 1999; Hurley et al 1997; Johnstona et al 2006; Stimson 1989; 
Tammi 2005; WHO 2004b; WHO UNODC UNAIDS 2009) decreasing needle 
sharing (through needle/syringe programmes, needle/syringe vending machines, 
and pharmacy provision),bleach and paraphernalia distribution, drug content testing
Some Suggestions for Moving Forward
“Law enforcement 
and harm reduction 
are not necessarily 
mutually exclusive 
(Stevens et al 2010), 
and it is argued that 
“(l)aw enforcement 
efforts should focus 
not on reducing drug 
markets per se but 
rather on reducing 
their harms” 
(Global Commission on 
Drug Policy 2011).
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(such as pill testing available in the Netherlands), straw (for snorting) provision, foil 
(for smoking heroin) provision, street-based outreach work, referral, disseminating 
information, education/peer education regarding risk behaviours (including sex 
education), condom provision, counselling and testing services, legal and social 
services, stigma reduction programmes, naloxone as part of overdose prevention 
work, and opiate substitution programmes.
Some harm reduction discourse deliberately positions itself neutrally (International 
Federation of Red Cross and Red Crescent Societies 2003; Tammi and Hurme 2006), 
differing from a prohibitionist approach in that it does not aspire to a reduction of 
drug use (Drucker et al 1998). Though prohibitionism is argued to increase harms 
surrounding drug use – and is thus seemingly incompatible with a harm reduction 
philosophy – harm reduction and prohibitionism are not necessarily mutually exclusive: 
many people are currently involved in drug use, and harm reduction may therefore 
be deployed to mitigate the surrounding harms within current (arguably harmful) 
legislative frameworks (Tammi 2005; UNODC 2008). It is, however, a promotion 
of welfare and health – coupled with active efforts to reduce harm – that should be 
sought, to the deprioritisation of the moral and ideological goals of prohibition. I 
should stress also that ultimately what is required is an end to prohibition, if the 
harms surrounding drug use are ever to truly and comprehensively be addressed, 
given that it is prohibition itself that so dramatically and demonstrably drives and 
exacerbates so many of these harms.
Reducing Harm: Moving Away from Stigma
Further to a nuanced and evidence-driven assessment of drugs and a concerted effort 
to reduce the harms that may be associated with drug use (arguably impossible 
without being accompanied by a decriminalisation of drug use, where criminalisation 
itself precipitates harm), it is emphasised that people who use drugs should not be 
regarded as deviant or inherently problematic, and should be entitled to the same 
citizenship and rights as the rest of the populace; problematisations of people who 
use drugs stemming from aforementioned discourses of addiction, for example, 
“should be resisted or at least questioned” (Keane 2002: 189). 
Due to their connotation and implication, the terms ‘addict’ and ‘addiction’ are argued 
to be “pejorative and stigmatising” (Larkin et al 2006: 207-208); terminology should 
therefore be contested and used carefully, addressing reductionist and derogatory 
assumptions (Larkin et al 2006). The construction of the diseased ‘addict’ or ‘drug 
abuser’ (see INPUD 2011) with a “pathological relationship between the subject and 
the substance” (Keane 2002: 37), the addict assumed as a ‘sick person’, may thus give 
way to a more neutral idea of a ‘drug user’ (Stimson 1987), or ‘people who use drugs’ 
(INPUD 2011). 
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“Our terminology, like 
drug classification, 
should be more 
objective, more 
descriptive, and less 
open to subjective 
assumption.”
Drug user networks such as the International Network of People who Use Drugs 
(INPUD 2011) prefer ‘people who use drugs’ as a less reductive alternative to the 
nounifying (apologies for the wordoid) ‘drug users’, and I have used this more neutral 
and descriptive term in this paper. Other terms, like ‘problem’ drug user (criticised 
above), should perhaps serve the purpose of being a more accurate reflection of an 
individual’s situation, connoting drug use that has become problematic for a person, 
not a blanket term generalising all of a heavily stigmatised ‘type’ of drug use(r). Our 
terminology, like drug classification, should be more objective, more descriptive, 
and less open to subjective assumption. Who is anyone to assume that injecting or 
dependence is, by default, problematic, especially given that many of the harms that 
may result – both to the individual and to society – in the first place stem from such 
moralistic problematisation, and the criminalisation that results? Who is anyone to 
superimpose their own desires, aversions, and interpretations onto another individual’s 
engagement with their own body and mind?
Ideas and terms continue to change and adjust, with Vrecko (2010) noting that 
dependence/addiction has been viewed as a ‘hybrid entity’, with medical, biological, 
moral, spiritual, and psychological analyses all historically playing roles. Favoured 
terms and understandings will, no doubt, continue to transform and transmogrify 
over time; what is imperative, though, is that understanding and assumption should 
be broken down and contested. Terminology and metaphor are, as I have been at 
pains to emphasise, enormously powerful. Our choice of terminology, of metaphor, 
of construction, should therefore not be a blasé one. Further, our efforts to destabilise 
and tackle issues of stigma need to engage with multiple stigmas and stigmas of varying 
intensity, “comprehensive interventions that are multilevel and address intersectional 
forms of stigma” (Logie et al 2011).
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In Conclusion: Prioritising Health, 
Inclusion, and Intersectionality
In summary, mainstream understanding and legislative classification and 
criminalisation of substances referred to here as ‘drugs’ is far from an indicative 
gauge of true harm. Ironically and circularly, it is the very criminalisation – and the 
stigmatisation and social construction that are relied upon to repress and marginalise 
people who use drugs, to render them as deviant – that drives and exacerbates much of 
the harm associated with drug use. In short, criminalisation and stigmatisation drive 
harm (and each other), which in turn serves to legitimise and justify criminalisation 
and stigma; intricate feedback loops indeed. 
In order to decrease the harms surrounding drug use, policy should be pragmatic 
and assessed on real outcomes (Tammi and Hurme 2006). A move towards harm 
reduction, towards pragmatism, towards policies and laws based on empirical 
evidence and on a human rights and health perspective – not a punitive and moralistic 
one – is surely the only option where, as argued by Des Jarlais:
“Nonmedical use of psychoactive drugs is inevitable in any society that has access 
to such drugs. Drug policies cannot be based on a utopian belief that nonmedical 
drug use will be eliminated.” (Des Jarlais 1995: 10)
In the context of disempowering social construction, social spoiling, and assumption, 
systematically serving to undermine agency and to silence the voices of people who 
use drugs themselves, decision making, policy, research, and legislation should be 
informed by those to whom it pertains (see AIVL 2006; Byrne and Albers 2010; 
Hunt et al 2009; Jürgens 2008). Indeed, the slogan “nothing about us without us”, 
first adopted by the disability rights movement, has been taken on by drug user rights 
organisations (Jürgens 2008), emphasising the importance of their contribution 
and inclusion. 
As I have stressed, many of the difficulties faced by people who use drugs, sex workers, 
and LGBTQ communities can be similar. It is no coincidence that this same ‘nothing 
about us without us’ slogan has been taken on by sex worker activists (International 
Sex Worker Harm Reduction Caucus 2008), where sex workers can face the same 
opposition to the implementation of sex work-related harm reduction initiatives, and 
similar issues relating to marginalisation, disempowerment, and an undermining of 
agency, a group whose own contribution to the formation of law and policy is also 
advocated in the context of their absence and exclusion (see International Sex Worker 
Harm Reduction Caucus 2008; Rekart 2005; UNAIDS 2009).
mainstream 
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classification and 
criminalisation of 
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far from an indicative 
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10	 For	example,	though	there	can	be	intersections	between	sex	work	and	drug	use,	generalising	sex	workers	as	people	who	use	drugs	(or	visa	versa)	 
	 would	be	both	simplistic,	and	inaccurate	(Cusick	et	al	2009;	Spice	2007).
A need to recognise and maximise opportunities and efforts 
of sex workers and people who use drugs alike to organise, 
network, and peer-educate is key as a means to the end of 
exclusion and the promotion of rights and health  
(for drug use, see AIVL 2006; Hunt et al 2010; Jürgens 2008; for sex work, 
see Brooks-Gordon 2006; Sanders and Campbell 2007; Scambler et al 1990; 
UNAIDS 2009; Ward 2007). 
A need to recognise and maximise opportunities and efforts of sex workers 
and people who use drugs alike to organise, network, and peer-educate is key 
as a means to the end of exclusion and the promotion of rights and health 
(for drug use, see AIVL 2006; Hunt et al 2010; Jürgens 2008; for sex work, see 
Brooks-Gordon 2006; Sanders and Campbell 2007; Scambler et al 1990; UNAIDS 
2009; Ward 2007). Thus, calls for inclusivity, activism, peer-empowerment, and 
peer-education should be seen from a perspective of commonality in struggle, from 
a perspective of intersectionality that encourages collective action and solidarity (see 
Crenshaw 1989; Crenshaw 1991).
I am certainly not asserting that these groups are identical in their struggles, their 
identities, or their social constructions, and one must be wary of conflations and crude 
overlapping (though certainly there can be intersection amongst these communities, 
and as mentioned above, stigma may be shared and assumed),10 as well as sensitive 
to intragroup variability and difference (Crenshaw 1991). What is clear, however, is 
that the means by which some groups have been criminalised, subjugated, oppressed, 
demonised, and cast out of normative society, are strikingly similar. Though fought 
on multiple fronts, these are parallel battles for autonomy and empowerment in the 
face of crosscutting social exclusion, control, stigmatisation, and an undermining 
of agency and self-determination, battles against the same modes of silencing, 
pathologisation, and disempowerment.
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